In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.
Session

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

Topic : Diabetes and the Heart

  • Session type : Satellite Symposium
  • Date : 19 April 2018
  • Time : 14:45 - 15:45
  • Sponsored by PACE-CME: Physicians' Academy for Cardiovascular Education, supported with an educational grant by Novo Nordisk.

5 presentations in this session

Introduction - Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

  • Session : Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.
  • Speaker : DE Grobbee (Utrecht,NL)
  • Sponsored by PACE-CME: Physicians' Academy for Cardiovascular Education, supported with an educational grant by Novo Nordisk.

The cardiovascular challenge for primary care in diabetes.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

  • Session : Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.
  • Speaker : R Hobbs (Oxford,GB)
  • Sponsored by PACE-CME: Physicians' Academy for Cardiovascular Education, supported with an educational grant by Novo Nordisk.

Diabetes: how to reduce risk from a cardiovascular perspective?

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

  • Session : Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.
  • Speaker : DE Grobbee (Utrecht,NL)
  • Sponsored by PACE-CME: Physicians' Academy for Cardiovascular Education, supported with an educational grant by Novo Nordisk.

Practical management of cardiovascular risk: lessons from latest diabetes trials.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

  • Session : Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.
  • Speaker : L Ryden (Stockholm,SE)
  • Sponsored by PACE-CME: Physicians' Academy for Cardiovascular Education, supported with an educational grant by Novo Nordisk.

Discussion - Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

  • Session : Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.
  • Speaker : DE Grobbee (Utrecht,NL), R Hobbs (Oxford,GB), L Ryden (Stockholm,SE)
  • Sponsored by PACE-CME: Physicians' Academy for Cardiovascular Education, supported with an educational grant by Novo Nordisk.

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are